The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro
ATP-sensitive K(+) (K(ATP)) channel activation is implicated in the vascular hyporeactivity occurring in septic shock. However, channel inhibition with the sulphonylurea receptor (SUR) antagonist, glibenclamide (Glib) fails to reverse lipopolysaccharide (LPS)-induced vascular hyporeactivity in vitro...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2005-02, Vol.144 (3), p.367-375 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 375 |
---|---|
container_issue | 3 |
container_start_page | 367 |
container_title | British journal of pharmacology |
container_volume | 144 |
creator | O'Brien, Alastair J Thakur, Gita Buckley, James F Singer, Mervyn Clapp, Lucie H |
description | ATP-sensitive K(+) (K(ATP)) channel activation is implicated in the vascular hyporeactivity occurring in septic shock. However, channel inhibition with the sulphonylurea receptor (SUR) antagonist, glibenclamide (Glib) fails to reverse lipopolysaccharide (LPS)-induced vascular hyporeactivity in vitro. We investigated whether inhibitors that act by binding to the K(ATP) channel pore could be effective. Ring segments of endothelium-intact rat mesenteric artery were incubated with LPS in culture media for either 6 or 20 h before contractile responses to phenylephrine were assessed in the absence or presence of K(ATP) channel inhibitors. The pore-forming subunit inhibitors barium chloride (BaCl(2); 300 microM) and PNU-37883A (1 microM) significantly reversed hyporeactivity at both time points, although less so at 20 h. In contrast, the SUR inhibitors, Glib (10 microM), tolbutamide (Tolb) (1 mM) and PNU-99963 (1 microM) were ineffective. In LPS-incubated tissues, Glib and Tolb antagonised contractions to the thromboxane A2 mimetic, U46619 (9,11-dideoxy-9alpha, 11alpha-methanoepoxy prostaglandin F(2alpha)) (10(-7) M), whereas the pinacidil-derived inhibitor, PNU-99963, did not. Contractions to 60 mM KCl were unaffected by LPS at 6 h, but were significantly depressed by LPS at 20 h, suggesting that K(+)-channel-independent pathways contribute to hyporeactivity at the later time point. The inducible nitric oxide synthase (iNOS) inhibitor, 1400 W (10 microM) and Tolb inhibited the production of nitrite induced by LPS, whereas BaCl(2) and PNU-37883A had no effect. In conclusion, K(ATP) channels contribute to LPS-induced vascular hyporeactivity via the iNOS pathway in rat mesenteric artery. The effectiveness of pore inhibitors over SUR inhibitors of the K(ATP) channel suggests altered SUR function following LPS administration, which cannot be explained by thromboxane receptor inhibition. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67410043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67410043</sourcerecordid><originalsourceid>FETCH-LOGICAL-p549-e31baefeafb55a387266114b0e9d83f2721c2b0832a673a2237f842fd4e94423</originalsourceid><addsrcrecordid>eNo1kEtLw0AUhbNQbK3-BZmV6CIwz0yyLMUXFiy0-3CT3GlHkkmcmRS686cbqa7O4jsPOBfJnFKqU8byfJZch_BJKZNaq6tkxlSmlGLFPPneHZAMvcfU9L6zbk_CWI3ORtIbEif2_rDcbR5JfQDnsCU2EHDEdlMkgouk61usxxY8ieD3GMlUQ9abbWpdM9bYkCOEMz-cfmegjvZo44lYRyb1_U1yaaANePuni2T7_LRbvabrj5e31XKdDkoWKQpWARoEUykFItc8yxiTFcWiyYXhmrOaVzQXHDItgHOhTS65aSQWUnKxSO7PrYPvv0YMsexsqLFtwWE_hjLTklEqxWS8-zOOVYdNOXjbgT-V_4-JHyvuZ7s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67410043</pqid></control><display><type>article</type><title>The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>O'Brien, Alastair J ; Thakur, Gita ; Buckley, James F ; Singer, Mervyn ; Clapp, Lucie H</creator><creatorcontrib>O'Brien, Alastair J ; Thakur, Gita ; Buckley, James F ; Singer, Mervyn ; Clapp, Lucie H</creatorcontrib><description>ATP-sensitive K(+) (K(ATP)) channel activation is implicated in the vascular hyporeactivity occurring in septic shock. However, channel inhibition with the sulphonylurea receptor (SUR) antagonist, glibenclamide (Glib) fails to reverse lipopolysaccharide (LPS)-induced vascular hyporeactivity in vitro. We investigated whether inhibitors that act by binding to the K(ATP) channel pore could be effective. Ring segments of endothelium-intact rat mesenteric artery were incubated with LPS in culture media for either 6 or 20 h before contractile responses to phenylephrine were assessed in the absence or presence of K(ATP) channel inhibitors. The pore-forming subunit inhibitors barium chloride (BaCl(2); 300 microM) and PNU-37883A (1 microM) significantly reversed hyporeactivity at both time points, although less so at 20 h. In contrast, the SUR inhibitors, Glib (10 microM), tolbutamide (Tolb) (1 mM) and PNU-99963 (1 microM) were ineffective. In LPS-incubated tissues, Glib and Tolb antagonised contractions to the thromboxane A2 mimetic, U46619 (9,11-dideoxy-9alpha, 11alpha-methanoepoxy prostaglandin F(2alpha)) (10(-7) M), whereas the pinacidil-derived inhibitor, PNU-99963, did not. Contractions to 60 mM KCl were unaffected by LPS at 6 h, but were significantly depressed by LPS at 20 h, suggesting that K(+)-channel-independent pathways contribute to hyporeactivity at the later time point. The inducible nitric oxide synthase (iNOS) inhibitor, 1400 W (10 microM) and Tolb inhibited the production of nitrite induced by LPS, whereas BaCl(2) and PNU-37883A had no effect. In conclusion, K(ATP) channels contribute to LPS-induced vascular hyporeactivity via the iNOS pathway in rat mesenteric artery. The effectiveness of pore inhibitors over SUR inhibitors of the K(ATP) channel suggests altered SUR function following LPS administration, which cannot be explained by thromboxane receptor inhibition.</description><identifier>ISSN: 0007-1188</identifier><identifier>PMID: 15655519</identifier><language>eng</language><publisher>England</publisher><subject>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology ; Animals ; ATP-Binding Cassette Transporters - agonists ; ATP-Binding Cassette Transporters - antagonists & inhibitors ; In Vitro Techniques ; Indicators and Reagents ; Isometric Contraction - drug effects ; KATP Channels ; Lipopolysaccharides - pharmacology ; Male ; Mesenteric Arteries - drug effects ; Muscle, Smooth, Vascular - drug effects ; Nitric Oxide - metabolism ; Nitric Oxide Donors - pharmacology ; Nitrites - metabolism ; Potassium Channels ; Potassium Channels, Inwardly Rectifying - agonists ; Potassium Channels, Inwardly Rectifying - antagonists & inhibitors ; Potassium Chloride - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Drug - antagonists & inhibitors ; Receptors, Thromboxane - antagonists & inhibitors ; S-Nitroso-N-Acetylpenicillamine - pharmacology ; Sulfonylurea Receptors ; Vasoconstrictor Agents - pharmacology</subject><ispartof>British journal of pharmacology, 2005-02, Vol.144 (3), p.367-375</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15655519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Brien, Alastair J</creatorcontrib><creatorcontrib>Thakur, Gita</creatorcontrib><creatorcontrib>Buckley, James F</creatorcontrib><creatorcontrib>Singer, Mervyn</creatorcontrib><creatorcontrib>Clapp, Lucie H</creatorcontrib><title>The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>ATP-sensitive K(+) (K(ATP)) channel activation is implicated in the vascular hyporeactivity occurring in septic shock. However, channel inhibition with the sulphonylurea receptor (SUR) antagonist, glibenclamide (Glib) fails to reverse lipopolysaccharide (LPS)-induced vascular hyporeactivity in vitro. We investigated whether inhibitors that act by binding to the K(ATP) channel pore could be effective. Ring segments of endothelium-intact rat mesenteric artery were incubated with LPS in culture media for either 6 or 20 h before contractile responses to phenylephrine were assessed in the absence or presence of K(ATP) channel inhibitors. The pore-forming subunit inhibitors barium chloride (BaCl(2); 300 microM) and PNU-37883A (1 microM) significantly reversed hyporeactivity at both time points, although less so at 20 h. In contrast, the SUR inhibitors, Glib (10 microM), tolbutamide (Tolb) (1 mM) and PNU-99963 (1 microM) were ineffective. In LPS-incubated tissues, Glib and Tolb antagonised contractions to the thromboxane A2 mimetic, U46619 (9,11-dideoxy-9alpha, 11alpha-methanoepoxy prostaglandin F(2alpha)) (10(-7) M), whereas the pinacidil-derived inhibitor, PNU-99963, did not. Contractions to 60 mM KCl were unaffected by LPS at 6 h, but were significantly depressed by LPS at 20 h, suggesting that K(+)-channel-independent pathways contribute to hyporeactivity at the later time point. The inducible nitric oxide synthase (iNOS) inhibitor, 1400 W (10 microM) and Tolb inhibited the production of nitrite induced by LPS, whereas BaCl(2) and PNU-37883A had no effect. In conclusion, K(ATP) channels contribute to LPS-induced vascular hyporeactivity via the iNOS pathway in rat mesenteric artery. The effectiveness of pore inhibitors over SUR inhibitors of the K(ATP) channel suggests altered SUR function following LPS administration, which cannot be explained by thromboxane receptor inhibition.</description><subject>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology</subject><subject>Animals</subject><subject>ATP-Binding Cassette Transporters - agonists</subject><subject>ATP-Binding Cassette Transporters - antagonists & inhibitors</subject><subject>In Vitro Techniques</subject><subject>Indicators and Reagents</subject><subject>Isometric Contraction - drug effects</subject><subject>KATP Channels</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Male</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Donors - pharmacology</subject><subject>Nitrites - metabolism</subject><subject>Potassium Channels</subject><subject>Potassium Channels, Inwardly Rectifying - agonists</subject><subject>Potassium Channels, Inwardly Rectifying - antagonists & inhibitors</subject><subject>Potassium Chloride - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Drug - antagonists & inhibitors</subject><subject>Receptors, Thromboxane - antagonists & inhibitors</subject><subject>S-Nitroso-N-Acetylpenicillamine - pharmacology</subject><subject>Sulfonylurea Receptors</subject><subject>Vasoconstrictor Agents - pharmacology</subject><issn>0007-1188</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtLw0AUhbNQbK3-BZmV6CIwz0yyLMUXFiy0-3CT3GlHkkmcmRS686cbqa7O4jsPOBfJnFKqU8byfJZch_BJKZNaq6tkxlSmlGLFPPneHZAMvcfU9L6zbk_CWI3ORtIbEif2_rDcbR5JfQDnsCU2EHDEdlMkgouk61usxxY8ieD3GMlUQ9abbWpdM9bYkCOEMz-cfmegjvZo44lYRyb1_U1yaaANePuni2T7_LRbvabrj5e31XKdDkoWKQpWARoEUykFItc8yxiTFcWiyYXhmrOaVzQXHDItgHOhTS65aSQWUnKxSO7PrYPvv0YMsexsqLFtwWE_hjLTklEqxWS8-zOOVYdNOXjbgT-V_4-JHyvuZ7s</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>O'Brien, Alastair J</creator><creator>Thakur, Gita</creator><creator>Buckley, James F</creator><creator>Singer, Mervyn</creator><creator>Clapp, Lucie H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro</title><author>O'Brien, Alastair J ; Thakur, Gita ; Buckley, James F ; Singer, Mervyn ; Clapp, Lucie H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p549-e31baefeafb55a387266114b0e9d83f2721c2b0832a673a2237f842fd4e94423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology</topic><topic>Animals</topic><topic>ATP-Binding Cassette Transporters - agonists</topic><topic>ATP-Binding Cassette Transporters - antagonists & inhibitors</topic><topic>In Vitro Techniques</topic><topic>Indicators and Reagents</topic><topic>Isometric Contraction - drug effects</topic><topic>KATP Channels</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Male</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Donors - pharmacology</topic><topic>Nitrites - metabolism</topic><topic>Potassium Channels</topic><topic>Potassium Channels, Inwardly Rectifying - agonists</topic><topic>Potassium Channels, Inwardly Rectifying - antagonists & inhibitors</topic><topic>Potassium Chloride - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Drug - antagonists & inhibitors</topic><topic>Receptors, Thromboxane - antagonists & inhibitors</topic><topic>S-Nitroso-N-Acetylpenicillamine - pharmacology</topic><topic>Sulfonylurea Receptors</topic><topic>Vasoconstrictor Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Brien, Alastair J</creatorcontrib><creatorcontrib>Thakur, Gita</creatorcontrib><creatorcontrib>Buckley, James F</creatorcontrib><creatorcontrib>Singer, Mervyn</creatorcontrib><creatorcontrib>Clapp, Lucie H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Brien, Alastair J</au><au>Thakur, Gita</au><au>Buckley, James F</au><au>Singer, Mervyn</au><au>Clapp, Lucie H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2005-02</date><risdate>2005</risdate><volume>144</volume><issue>3</issue><spage>367</spage><epage>375</epage><pages>367-375</pages><issn>0007-1188</issn><abstract>ATP-sensitive K(+) (K(ATP)) channel activation is implicated in the vascular hyporeactivity occurring in septic shock. However, channel inhibition with the sulphonylurea receptor (SUR) antagonist, glibenclamide (Glib) fails to reverse lipopolysaccharide (LPS)-induced vascular hyporeactivity in vitro. We investigated whether inhibitors that act by binding to the K(ATP) channel pore could be effective. Ring segments of endothelium-intact rat mesenteric artery were incubated with LPS in culture media for either 6 or 20 h before contractile responses to phenylephrine were assessed in the absence or presence of K(ATP) channel inhibitors. The pore-forming subunit inhibitors barium chloride (BaCl(2); 300 microM) and PNU-37883A (1 microM) significantly reversed hyporeactivity at both time points, although less so at 20 h. In contrast, the SUR inhibitors, Glib (10 microM), tolbutamide (Tolb) (1 mM) and PNU-99963 (1 microM) were ineffective. In LPS-incubated tissues, Glib and Tolb antagonised contractions to the thromboxane A2 mimetic, U46619 (9,11-dideoxy-9alpha, 11alpha-methanoepoxy prostaglandin F(2alpha)) (10(-7) M), whereas the pinacidil-derived inhibitor, PNU-99963, did not. Contractions to 60 mM KCl were unaffected by LPS at 6 h, but were significantly depressed by LPS at 20 h, suggesting that K(+)-channel-independent pathways contribute to hyporeactivity at the later time point. The inducible nitric oxide synthase (iNOS) inhibitor, 1400 W (10 microM) and Tolb inhibited the production of nitrite induced by LPS, whereas BaCl(2) and PNU-37883A had no effect. In conclusion, K(ATP) channels contribute to LPS-induced vascular hyporeactivity via the iNOS pathway in rat mesenteric artery. The effectiveness of pore inhibitors over SUR inhibitors of the K(ATP) channel suggests altered SUR function following LPS administration, which cannot be explained by thromboxane receptor inhibition.</abstract><cop>England</cop><pmid>15655519</pmid><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2005-02, Vol.144 (3), p.367-375 |
issn | 0007-1188 |
language | eng |
recordid | cdi_proquest_miscellaneous_67410043 |
source | MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology Animals ATP-Binding Cassette Transporters - agonists ATP-Binding Cassette Transporters - antagonists & inhibitors In Vitro Techniques Indicators and Reagents Isometric Contraction - drug effects KATP Channels Lipopolysaccharides - pharmacology Male Mesenteric Arteries - drug effects Muscle, Smooth, Vascular - drug effects Nitric Oxide - metabolism Nitric Oxide Donors - pharmacology Nitrites - metabolism Potassium Channels Potassium Channels, Inwardly Rectifying - agonists Potassium Channels, Inwardly Rectifying - antagonists & inhibitors Potassium Chloride - pharmacology Rats Rats, Sprague-Dawley Receptors, Drug - antagonists & inhibitors Receptors, Thromboxane - antagonists & inhibitors S-Nitroso-N-Acetylpenicillamine - pharmacology Sulfonylurea Receptors Vasoconstrictor Agents - pharmacology |
title | The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T09%3A30%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20pore-forming%20subunit%20of%20the%20K(ATP)%20channel%20is%20an%20important%20molecular%20target%20for%20LPS-induced%20vascular%20hyporeactivity%20in%20vitro&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=O'Brien,%20Alastair%20J&rft.date=2005-02&rft.volume=144&rft.issue=3&rft.spage=367&rft.epage=375&rft.pages=367-375&rft.issn=0007-1188&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E67410043%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67410043&rft_id=info:pmid/15655519&rfr_iscdi=true |